Public Profile

Yun Nan Yong An Pharmaceuticals Inc.

Yun Nan Yong An Pharmaceuticals Inc., a prominent player in the pharmaceutical industry, is headquartered in Yunnan, China, with significant operations across various regions. Founded in 1998, the company has established itself as a leader in the development and manufacturing of traditional Chinese medicine and modern pharmaceuticals. Yun Nan Yong An is renowned for its unique herbal formulations and innovative drug delivery systems, which cater to a diverse range of health conditions. The company has achieved notable milestones, including certifications for quality management systems and recognition for its commitment to research and development. With a strong market position, Yun Nan Yong An Pharmaceuticals continues to expand its footprint, contributing to the global healthcare landscape while promoting the benefits of traditional medicine.

DitchCarbon Score

How does Yun Nan Yong An Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Yun Nan Yong An Pharmaceuticals Inc.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Yun Nan Yong An Pharmaceuticals Inc.'s reported carbon emissions

Yun Nan Yong An Pharmaceuticals Inc. currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as Science-Based Targets Initiative (SBTi) goals or other climate pledges. In the absence of specific data, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt comprehensive climate strategies to mitigate their environmental impact. Yun Nan Yong An Pharmaceuticals Inc. may benefit from establishing clear emissions reduction targets and engaging in climate commitments to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Yun Nan Yong An Pharmaceuticals Inc.'s primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Yun Nan Yong An Pharmaceuticals Inc. is in , which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Yun Nan Yong An Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Biostar Pharmaceuticals, Inc.

CN
Pharmaceutical Preparation Manufacturing
Updated 20 minutes ago

Fu Zhou Min Hai Pharmaceutical, Co., Ltd

CN
Pharmaceutical Preparation Manufacturing
Updated 20 minutes ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers